BofA/Merrill Lynch Downgrades Impax Laboratories (IPXL) to Underperform

November 7, 2016 7:12 AM EST
Get Alerts IPXL Hot Sheet
Price: $13.65 -0.73%

Rating Summary:
    9 Buy, 15 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade IPXL Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

BofA/Merrill Lynch downgraded Impax Laboratories (NASDAQ: IPXL) from Neutral to Underperform with a price target of $19.00.

For an analyst ratings summary and ratings history on Impax Laboratories click here. For more ratings news on Impax Laboratories click here.

Shares of Impax Laboratories closed at $17.75 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment